Amit Khurana of Dolat Capital anticipates limited market movement in the coming quarter due to headwinds, suggesting a cooling period before renewed buying. Upside potential is capped, while downside risk is protected. He advises a neutral stance on the pharma sector for FY26, citing normalizing tailwinds and US trade tariffs, but favors JB, Ajanta, Cipla, and Torrent.
Silver hits $60 per ounce for first time, gold rises ahead of Fed rate decision
Gold prices edged higher as traders anticipated the U.S. Federal Reserve’s interest rate decision. Meanwhile, silver surged to an all-time high of over $60 per